Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Xiao Jian Ni"'
Autor:
Bo-Hao Zheng, Cheng Zhang, Wen-Ze Wan, Wen-Tao Sun, Xi Cheng, Xiao-Jian Ni, Xiao-Ling Ni, Tao Suo, Han Liu, Sheng Shen, Hou-Bao Liu
Publikováno v:
BMC Surgery, Vol 22, Iss 1, Pp 1-10 (2022)
Abstract Background In this study, we aimed at elucidating the postoperative survival and prognostic factors in patients with biliary neuroendocrine neoplasm (NEN). Methods Cases of biliary system NEN and adenocarcinoma from 1975 to 2016 were extract
Externí odkaz:
https://doaj.org/article/977db70e4eb348f18a2ac199bc789674
Autor:
Sheng Shen, Ji‐Wen Wang, Bo‐Hao Zheng, Xiao‐Jian Ni, Zhi‐Hui Gao, De‐Xiang Zhang, Ping‐Xiang Lu, Xiao‐Ling Ni, Tao Suo, Hou‐Bao Liu, Han Liu
Publikováno v:
Clinical and Translational Medicine, Vol 10, Iss 2, Pp n/a-n/a (2020)
Externí odkaz:
https://doaj.org/article/bbe6aeea2c50430c836614f40c410086
Autor:
Luying Li, Xiuling Zhi, Li Wang, Ping Zhou, Jerry Yu, Youping Jin, Yi-Hong Luo, Xue Wang, Yangbai Sun, Wenbo Wei, Xiao-Jian Ni, Qi Lu, Wei Zhu
Publikováno v:
Cell Adhesion & Migration, Vol 15, Iss 1, Pp 140-151 (2021)
Cell Adhesion & Migration
article-version (VoR) Version of Record
Cell Adhesion & Migration
article-version (VoR) Version of Record
LncRNA plays a critical role in tumor progression. However, the role it executes in breast cancer is still unclear. Here, we report a newly discovered lncRNA, ENST00000508435, which could be remarkably up-regulated in breast cancer cells and tissues.
Autor:
Xiao-Jian Ni, Juan Zhang, Jingjing Ma, Wei Zhu, Zhixian He, Zhi-Min Shao, Hongwei Zhang, Bohao Zheng
Publikováno v:
Cancer Management and Research
Bo-Hao Zheng,1,2,* Zhi-Xian He,3,* Juan Zhang,4,* Jing-Jing Ma,5,* Hong-Wei Zhang,1,2 Wei Zhu,1,2 Zhi-Min Shao,6 Xiao-Jian Ni1,2 1Department of General Surgery, Zhongshan Hospital, Fudan University, Shanghai, 200032, Peopleâs Rep
Autor:
Xiao-Jian Ni, Xiao-Lan Zhang, Qian-Wen Ou-Yang, Guo-Wei Qian, Lei Wang, Sheng Chen, Yi-Zhou Jiang, Wen-Jia Zuo, Jiong Wu, Xin Hu, Zhi-Ming Shao
Publikováno v:
PLoS ONE, Vol 9, Iss 11, p e111886 (2014)
PURPOSE: Neoadjuvant chemotherapy (NCT) is a standard treatment option for locally advanced breast cancer. However, the lack of an efficient method to predict treatment response and patient prognosis hampers the clinical evaluation of patient eligibi
Externí odkaz:
https://doaj.org/article/a9c3f56493834da2a68ca97e44737299
Autor:
Cheng-Zhe Cai, Yi-Hong Luo, Jia-Liang Cai, Jun-Xian Du, Cong Chen, Jing Xu, Wei Zhu, Xiao-Jian Ni
Publikováno v:
Gene. 762
There exists considerable evidence conforming that autophagy may play an important role in the biological process of breast cancer. This study aimed to construct and evaluate a novel autophagy-related gene signature as a potential prognostic factor a
Publikováno v:
Pathology - Research and Practice. 214:1648-1654
NIMA Related Kinase 6 (Nek6) is a protein kinase involved in various cellular processes, including cell cycle regulation, apopotosis, senescence, telomere maintainance and chemoresistance. In the present study, we investigated the role of Nek6 in bre
Autor:
Tianbao Huang, Na Wang, Yun Xia, Peipei Ding, Shan Li, Sheng Chen, Long Zhang, Fugui Ye, Rongcheng Luo, Zhiming Shao, Yiqun Du, Yi-Zhou Jiang, Chaoqun Yang, Weiguo Hu, Xiao-Jian Ni, Qianwen Ouyang, Liang Huang, Yujing Sun
Publikováno v:
International Journal of Oncology. 48:2015-2024
Breast cancer is the most prevalent type of cancer among women. CD59, a membrane complement regulatory protein, has been demonstrated to be overexpressed in most solid tumors, where it facilitates tumor cell escape from complement surveillance. Howev
Autor:
Guo-Wei Qian1, Xiao-Jian Ni1, Zheng Wang2, Yi-Zhou Jiang1, Ke-Da Yu1, Zhi-Ming Shao1 zhiming_shao@163.com
Publikováno v:
OncoTargets & Therapy. 2015, Vol. 8, p1407-1418. 12p.
Autor:
Zhi-Ming Shao, Xiao-Jian Ni, Xin Hu, Lei Wang, Xiao-Lan Zhang, Sheng Chen, Qianwen Ouyang, Guo-Wei Qian, Yi-Zhou Jiang
Publikováno v:
Cancer Research. 75:P3-11
Neoadjuvant chemotherapy (NAC) is the standard of care for locally advanced breast cancer (LABC). However, the lack of efficient method to predict the treatment response and prognosis limits the clinical evaluation of the patient eligibility. Elevate